keyword
https://read.qxmd.com/read/38421347/psychopathological-symptoms-in-fibromyalgia-and-their-associations-with-resistance-to-pharmacotherapy-with-snri
#21
JOURNAL ARTICLE
Anna Julia Krupa, Adrian Andrzej Chrobak, Zbigniew Sołtys, Mariusz Korkosz, Jaroslaw Nowakowski, Dominika Dudek, Marcin Siwek
OBJECTIVES: Fibromyalgia (FM) is often comorbid with psychiatric disorders. Moreover, several studies show that psychiatric disorders may be linked to the severity and impact of FM. Therefore, the study described in the article had two main goals: (1) to explore various psychopathological symptom dimensions in patients with fibromyalgia and secondly, (2) to examine the links between psychopathology and response to treatment with serotonin and norepinephrine reuptake inhibitors (SNRI)...
February 5, 2024: Psychiatria Polska
https://read.qxmd.com/read/38406216/serotonin-syndrome-an-often-neglected-medical-emergency
#22
REVIEW
Ahmed Badar
Optimum serotonin level in the serotonergic synapses of the central nervous system (CNS) is related to mood, behavior, and sleep. Serotonin syndrome (SS) is a rare yet very dangerous adverse effect resulting from increased serotonin in CNS. The diagnosis of SS is based on the presence of clinical symptoms, which can include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremors, sweating, and diarrhea. SS is invariably caused by inadvertent use of serotonergic medicines...
2024: Journal of Family & Community Medicine
https://read.qxmd.com/read/38405806/individual-differences-in-the-boldness-of-female-zebrafish-are-associated-with-alterations-in-serotonin-function
#23
Fatemeh Beigloo, Cameron J Davidson, Joseph Gjonaj, Shane A Perrine, Justin W Kenney
One of the most prevalent axes of behavioral variation in both humans and animals is risk taking, where individuals that are more willing to take risk are characterized as bold while those that are more reserved as shy. Brain monoamines (i.e., serotonin, dopamine, and norepinephrine) have been found to play a role in a variety of behaviors related to risk taking. Genetic variation related to monoamine function have also been linked to personality in both humans and animals. Using zebrafish, we investigated the relationship between monoamine function and boldness behavior during exploration of a novel tank...
February 13, 2024: bioRxiv
https://read.qxmd.com/read/38401410/association-of-antidepressant-and-benzodiazepine-use-and-anticholinergic-burden-with-cognitive-performance-in-schizophrenia
#24
JOURNAL ARTICLE
Ville Mäkipelto, Annamari Tuulio-Henriksson, Christian Hakulinen, Solja Niemelä, Markku Lähteenvuo, Asko Wegelius, Tuula Kieseppä, Erkki Isometsä, Jari Tiihonen, Olli Kampman, Kaisla Lahdensuo, Atiqul Mazumder, Jaana Suvisaari, Minna Holm
Schizophrenia is characterized by cognitive impairment affecting everyday functioning. Earlier research has hypothesized that antidepressants may associate with better cognitive functioning, but results are mixed. This study explored the association between antidepressant use and cognitive performance in terms of reaction time and visual learning in a clinical sample. In addition, we examined benzodiazepine use and anticholinergic burden. Study participants were drawn from the SUPER-Finland cohort, collected among patients with psychotic illnesses in 2016-2018 throughout Finland (n = 10,410)...
February 23, 2024: Schizophrenia Research
https://read.qxmd.com/read/38396311/post-stroke-depression-in-older-adults-an-overview
#25
REVIEW
Fabio Giuseppe Masuccio, Erica Grange, Rachele Di Giovanni, Martina Rolla, Claudio Marcello Solaro
Detailed data on post-stroke depression (PSD) in older adults are limited in spite of the high vulnerability of this population to stroke. In fact, PSD prevalence in older adults ranges from 16.0 to 43.9%; however, timing and instruments of evaluation often differ significantly across all available studies. The etiology, genetic and inflammatory factors, as well as structural brain alterations, are claimed as part of a multifaceted mechanism of action in PSD onset. Thus, the aim of this narrative review was to further elaborate on the prevalence, etiology, diagnosis, consequences and treatment of PSD in older adults...
February 23, 2024: Drugs & Aging
https://read.qxmd.com/read/38394986/identification-of-new-risk-factors-for-hydroxychloroquine-and-chloroquine-retinopathy-in-systemic-lupus-erythematosus-patients
#26
JOURNAL ARTICLE
Ludovic Trefond, Raphael Lhote, Alexis Mathian, Marc Pineton de Chambrun, Micheline Pha, Miguel Hie, Makoto Miyara, Matthias Papo, Quentin Moyon, Dov Taieb, Sonia Saade, Thouraya Ben Salem, Julien Haroche, François Chasset, Fleur Cohen Aubart, Noël Zahr, Zahir Amoura
BACKGROUND: Long-term hydroxychloroquine (HCQ) or chloroquine (CQ) intake causes retinal toxicity in 0.3-8 % of patients with rheumatic diseases. Numerous risk factors have been described, eg, daily dose by weight, treatment duration, chronic kidney disease, concurrent tamoxifen therapy and pre-existing retinal or macular disease. However, those factors cannot explain the entire risk of developing antimalarial retinopathy. OBJECTIVE: This study was undertaken to identify new risk factors associated with HCQ or CQ retinopathy (QRNP) in systemic lupus erythematosus (SLE) patients...
February 12, 2024: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/38379028/comparative-responses-to-17-different-antidepressants-in-major-depressive-disorder-results-from-a-2-year-long-term-nation-wide-population-based-study-emulating-a-randomized-trial
#27
JOURNAL ARTICLE
Lars Vedel Kessing, Simon Christoffer Ziersen, Frederik Mølkjaer Andersen, Thomas Gerds, Esben Budtz-Jørgensen
BACKGROUND: Long-term studies comparing nonresponse to antidepressants for major depressive disorder (MDD) are lacking. AIMS: To present systematic population-based nation-wide register data on comparative 2-year non-response within six antidepressant drug classes and 17 different antidepressants in patients with MDD. METHOD: The study included all 106,920 patients in Denmark with a first main index diagnosis of MDD at a psychiatric hospital inpatient or outpatient contact and who subsequently had a purchase of an antidepressant in the period from 1995 to 2018...
February 20, 2024: Acta Psychiatrica Scandinavica
https://read.qxmd.com/read/38371081/nonhormonal-pharmacotherapies-for-the-treatment-of-postmenopausal-vasomotor-symptoms
#28
REVIEW
Taylor Witten, Julia Staszkiewicz, Logan Gold, Mallory A Granier, Rachel J Klapper, Gabriel Lavespere, Bradley Dorius, Varsha Allampalli, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye, Giustino Varrassi
An average of 60-80% of all menopausal women experience bothersome vasomotor symptoms (VMSs), such as flushing and sweating, within the first seven years of onset. However, despite increasing prevalence, these hot flashes remain hard to treat and have a negative effect on the quality of life. Though hormone replacement therapy is commonly utilized as a standard treatment for VMSs, this therapy is not recommended for all women. Specifically, the oral form of hormone replacement therapy is associated with several contraindications, including a history of thromboembolic disease, migraine headache with aura, liver failure, heart disease, and hormone-dependent cancers...
January 2024: Curēus
https://read.qxmd.com/read/38367846/low-dose-interleukin-2-antidepressant-potentiation-in-unipolar-and-bipolar-depression-safety-efficacy-and-immunological-biomarkers
#29
JOURNAL ARTICLE
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, Veronica Aggio, Annamaria Finardi, Cristina Lorenzi, Giovanna Borsellino, Matteo Carminati, Elena Manfredi, Enrico Tomasi, Sara Spadini, Cristina Colombo, Hemmo A Drexhage, Roberto Furlan, Francesco Benedetti
Immune-inflammatory mechanisms are promising targets for antidepressant pharmacology. Immune cell abnormalities have been reported in mood disorders showing a partial T cell defect. Following this line of reasoning we defined an antidepressant potentiation treatment with add-on low-dose interleukin 2 (IL-2). IL-2 is a T-cell growth factor which has proven anti-inflammatory efficacy in autoimmune conditions, increasing thymic production of naïve CD4 + T cells, and possibly correcting the partial T cell defect observed in mood disorders...
February 15, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38355065/duloxetine-as-an-analgesic-in-patients-who-do-not-have-central-sensitivity-undergoing-single-sitting-bilateral-total-knee-arthroplasty-a-prospective-double-blinded-randomized-placebo-controlled-trial
#30
JOURNAL ARTICLE
Amyn M Rajani, Anmol Rs Mittal, Vishal U Kulkarni, Megha Desai, Rishab Dubey, Khushi Rajani, Kashish Rajani
BACKGROUND: Pain control and patient satisfaction after total knee arthroplasty (TKA) have room for improvement. While studies have reported better analgesic outcomes with antidepressants like duloxetine in patients who do not have central sensitivity, we undertook this trial to determine the short and midterm analgesic role of low-dose duloxetine in patients who do not have central sensitivity. METHODS: This prospective, double-blinded, randomized, placebo-controlled trial was conducted in 106 patients undergoing single-sitting, bilateral TKA under spinal anesthesia...
February 12, 2024: Journal of Arthroplasty
https://read.qxmd.com/read/38349403/the-pathobiology-of-depression-in-huntington-s-disease-an-unresolved-puzzle
#31
REVIEW
Kurt A Jellinger
Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative disease that manifests with a triad of symptoms including motor dysfunctions, cognitive deficits, and prominent neuropsychiatric symptoms, the most common of which is depression, with a prevalence between 30 and 70%. Depressive symptoms occur in all stages of HD, beginning in presymptomatic HD gene carriers, and are strongly associated with suicidal ideation and suicidality, but their relationship with other clinical dimensions in HD is controversial and the underlying pathophysiology is poorly understood...
February 13, 2024: Journal of Neural Transmission
https://read.qxmd.com/read/38347994/desvenlafaxine-triggered-acneiform-eruptions-on-the-hand-a-compelling-case-report
#32
Anupam S Yadav, Sonali Singh, Jaismeen Randhawa, Chinaza M Akuma, Ogbonnaya Akuma, Hassan A Chaudhry
A 45-year-old male developed a skin eruption after starting Desvenlafaxine for depressive symptoms associated with schizophreniform disorder. The patient developed a rash on the hand, hyperpigmentation, and itching, which resolved after discontinuing the medication. The Naranjo score suggested a probable link between desvenlafaxine and the skin reaction. Stable vital signs and normal labs supported this conclusion. The case underscores the importance of recognizing and reporting adverse drug reactions, even with generally safe medications like desvenlafaxine...
January 2024: Curēus
https://read.qxmd.com/read/38336466/a-systematic-review-and-critical-appraisal-of-menopause-guidelines
#33
JOURNAL ARTICLE
Chandima Hemachandra, Sasha Taylor, Rakibul M Islam, Ensieh Fooladi, Susan R Davis
OBJECTIVE AND RATIONALE: To identify and appraise current national and international clinical menopause guidance documents, and to extract and compare the recommendations of the most robust examples. DESIGN: Systematic review. DATA SOURCES: Ovid MEDLINE, EMBASE, PsycINFO and Web of Science ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Practice guidance documents for menopause published from 2015 until 20 July 2023. Quality was assessed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument...
February 22, 2024: BMJ Sexual & Reproductive Health
https://read.qxmd.com/read/38327724/neuropathic-pain-medication-and-antidepressant-use-after-disability-pension-in-patients-with-spinal-cord-stimulation-for-persistent-spinal-pain-syndrome
#34
JOURNAL ARTICLE
Hanna Kaijankoski, Mette Nissen, Tiina-Mari Ikäheimo, Mikael von Und Zu Fraunberg, Olavi Airaksinen, Jukka Huttunen
BACKGROUND: Treatment of persistent spinal pain syndrome (PSPS) is challenging. Chronic pain associated with PSPS can lead to an impaired ability to work. OBJECTIVE: To obtain information on whether receiving a disability pension (DP) affects pain and pain treatments in retiring working-age PSPS patients. Neuropathic pain medication and antidepressant use were considered as an indicator of neuropathic pain. METHODS: The study group comprised 129 consecutive PSPS patients with spinal cord stimulation (SCS) devices implanted at Kuopio University Hospital Neurosurgery between January 1, 1996, and December 31, 2014...
2024: Pain Research & Management
https://read.qxmd.com/read/38315125/gender-affirming-surgery-improves-mental-health-outcomes-and-decreases-anti-depressant-use-in-patients-with-gender-dysphoria
#35
JOURNAL ARTICLE
Lee H Kilmer, Jesse Chou, Christopher A Campbell, Brent R DeGeorge, John T Stranix
BACKGROUND: Patients with gender dysphoria face significant health disparities and barriers to care. Transition-related care includes hormonal therapy, mental healthcare, and gender-affirming surgeries. Studies have described favorable surgical outcomes and patient satisfaction, however, the degree to which these procedures impact mental health conditions is not fully understood. The purpose of this study was to evaluate the effect of gender-affirming plastic surgery on mental health and substance abuse in the transgender population...
February 2, 2024: Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38287888/update-lessons-from-pet-imaging-part-ii-a-systematic-critical-review-on-therapeutic-plasma-concentrations-of-antidepressants
#36
JOURNAL ARTICLE
Xenia M Hart, Moritz Spangemacher, Julie Defert, Hiroyuki Uchida, Gerhard Gründer
BACKGROUND: Compared with antipsychotics, the relationship between antidepressant blood (plasma or serum) concentrations and target engagement is less well-established. METHODS: We have discussed the literature on the relationship between plasma concentrations of antidepressant drugs and their target occupancy. Antidepressants reviewed in this work are citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine, duloxetine, milnacipran, tricyclic antidepressants (amitriptyline, nortriptyline, and clomipramine), bupropion, tranylcypromine, moclobemide, and vortioxetine...
April 1, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38283019/prescription-practices-regarding-the-use-of-systemic-drugs-in-the-management-of-patients-with-chronic-pruritus-amongst-indian-dermatologists-a-questionnaire-based-survey
#37
JOURNAL ARTICLE
Kapil Vyas, Kriti Maheshwari, Praveen K Shanmugam Reddy, Rajesh Verma, Iffat Hasan, Asit Mittal
BACKGROUND: Chronic pruritus poses a significant challenge to treating physicians due to multitude of underlying causes and varying treatment strategies. Several topical, systemic, and physical modalities have been tried with variable success. Prescription practices in chronic pruritus are influenced by differential knowledge and experience of physicians, patient-related factors, and resource availability. AIM: The purpose of this survey was to observe the current pattern of practice in Indian dermatologists in the management of chronic pruritus and to identify practice gaps particularly regarding the use of various systemic agents as antipruritics...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38258436/patient-journey-of-civilian-adults-diagnosed-with-posttraumatic-stress-disorder-a-chart-review-study
#38
JOURNAL ARTICLE
Lori L Davis, Annette Urganus, Patrick Gagnon-Sanschagrin, Jessica Maitland, Jerome Bedard, Remi Bellefleur, Martin Cloutier, Annie Guérin, Jyoti Aggarwal
OBJECTIVE: To assess the journey of individuals from experiencing a traumatic event through onset of symptoms, diagnosis, and treatment of posttraumatic stress disorder (PTSD). METHODS: Patient- and psychiatrist-level data was collected (02/2022-05/2022) from psychiatrists who treated ≥1 civilian adult diagnosed with PTSD. Eligible charts covered civilian adults diagnosed with PTSD (2016-2020), receiving ≥1 PTSD-related treatment (selective serotonin reuptake inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors [SNRIs], atypical antipsychotics [AAs]), and having ≥1 medical visit in the last 12 months...
January 23, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38258064/systemic-and-brain-pharmacokinetics-of-milnacipran-in-mice-comparison-of-intraperitoneal-and-intravenous-administration
#39
JOURNAL ARTICLE
Sounak Bagchi, Ehsan Nozohouri, Yeseul Ahn, Dhavalkumar Patel, Ulrich Bickel, Vardan T Karamyan
Milnacipran is a dual serotonin and norepinephrine reuptake inhibitor, clinically used for the treatment of major depression or fibromyalgia. Currently, there are no studies reporting the pharmacokinetics (PK) of milnacipran after intraperitoneal (IP) injection, despite this being the primary administration route in numerous experimental studies using the drug. Therefore, the present study was designed to investigate the PK profile of IP-administered milnacipran in mice and compare it to the intravenous (IV) route...
December 29, 2023: Pharmaceutics
https://read.qxmd.com/read/38256902/use-of-exposure-data-to-establish-causality-in-drug-adverse-event-relationships-an-example-with-desvenlafaxine
#40
JOURNAL ARTICLE
Andrea Rodríguez-Lopez, Gina Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Causality algorithms help establish relationships between drug use and adverse event (AE) occurrence. High drug exposure leads to a higher likelihood of an AE being classified as an adverse drug reaction (ADR). However, there is a knowledge gap regarding what concentrations are predictive of ADRs, as this has not been systematically studied. In this work, the Spanish Pharmacovigilance System (SEFV) algorithm was used to define the relationship between the AE occurrence and drug administration in 178 healthy volunteers participating in five desvenlafaxine single-dose clinical trials, a selective serotonin and norepinephrine reuptake inhibitor that may cause dizziness, headache, nausea, dry mouth, constipation and hyperhidrosis...
January 3, 2024: Pharmaceuticals
keyword
keyword
32930
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.